Skip to content

IRADIMED CORPORATION: 10-Q filed 2017-11-06

What IRADIMED CORPORATION reported in its quarterly report filed 2017-11-06 (fiscal Q3 2017): 48 published measures, 138 facts as tagged in accession 0001104659-17-066294.

This filing

Form
10-Q (quarterly report)
Filed
2017-11-06
Fiscal period
fiscal Q3 2017
Accession
0001104659-17-066294 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All IRADIMED CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-09-3037,919,628USD
At 2016-12-3137,194,484USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-09-305,779,222USD
At 2016-12-315,305,359USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-09-3032,140,406USD
At 2016-12-3131,889,125USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-09-3018,406,305USD
At 2016-12-3117,713,871USD
At 2016-09-3016,004,062USD
At 2015-12-3119,368,114USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-07-01 to 2017-09-30192,393USD92
2017-01-01 to 2017-09-30316,126USD273
2016-07-01 to 2016-09-301,560,484USD92
2016-01-01 to 2016-09-306,073,745USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-01-01 to 2017-09-302,014,799USD273
2016-01-01 to 2016-09-307,182,627USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2017-01-01 to 2017-09-30653,171USD273
2016-01-01 to 2016-09-30547,087USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2017-07-01 to 2017-09-305,689,724USD92
2017-01-01 to 2017-09-3016,376,648USD273
2016-07-01 to 2016-09-307,673,217USD92
2016-01-01 to 2016-09-3026,506,275USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-01-01 to 2017-09-30-1,814,141USD273
2016-01-01 to 2016-09-30-9,202,022USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2017-01-01 to 2017-09-30491,776USD273
2016-01-01 to 2016-09-30-1,344,657USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-09-3020,171,907USD
At 2016-12-3119,869,714USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2017-07-01 to 2017-09-3010,565,598shares92
2017-01-01 to 2017-09-3010,664,132shares273
2016-07-01 to 2016-09-3010,684,650shares92
2016-01-01 to 2016-09-3010,852,476shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2017-07-01 to 2017-09-3011,643,044shares92
2017-01-01 to 2017-09-3011,710,377shares273
2016-07-01 to 2016-09-3011,867,997shares92
2016-01-01 to 2016-09-3012,055,467shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2017-07-01 to 2017-09-300.02USD/shares92
2017-01-01 to 2017-09-300.03USD/shares273
2016-07-01 to 2016-09-300.15USD/shares92
2016-01-01 to 2016-09-300.56USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2017-07-01 to 2017-09-300.02USD/shares92
2017-01-01 to 2017-09-300.03USD/shares273
2016-07-01 to 2016-09-300.13USD/shares92
2016-01-01 to 2016-09-300.5USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2017-07-01 to 2017-09-3032,384USD92
2017-01-01 to 2017-09-3048,507USD273
2016-07-01 to 2016-09-301,029,029USD92
2016-01-01 to 2016-09-303,364,179USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2017-09-301,853,506USD
At 2016-12-311,456,149USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-01-01 to 2017-09-301,735,078USD273
2016-01-01 to 2016-09-301,788,045USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-07-01 to 2017-09-30196,062USD92
2017-01-01 to 2017-09-30285,256USD273
2016-07-01 to 2016-09-302,593,530USD92
2016-01-01 to 2016-09-309,414,832USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-09-3033,447,155USD
At 2016-12-3133,856,401USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-09-303,850,875USD
At 2016-12-313,661,881USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2017-09-30794,446USD
At 2016-12-311,120,830USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2017-09-30885,713USD
At 2016-12-31918,712USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2017-09-303,508,432USD
At 2016-12-313,775,699USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2017-01-01 to 2017-09-301,818,542USD273
2016-01-01 to 2016-09-309,969,468USD274

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-07-01 to 2017-09-304,185,895USD92
2017-01-01 to 2017-09-3012,161,693USD273
2016-07-01 to 2016-09-303,673,803USD92
2016-01-01 to 2016-09-3012,240,695USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2017-09-304,129,357USD
At 2016-12-313,886,590USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2017-07-01 to 2017-09-304,381,957USD92
2017-01-01 to 2017-09-3012,446,949USD273
2016-07-01 to 2016-09-306,267,333USD92
2016-01-01 to 2016-09-3021,655,527USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2017-07-01 to 2017-09-301,307,767USD92
2017-01-01 to 2017-09-303,929,699USD273
2016-07-01 to 2016-09-301,405,884USD92
2016-01-01 to 2016-09-304,850,748USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-07-01 to 2017-09-30382,704USD92
2017-01-01 to 2017-09-301,373,005USD273
2016-07-01 to 2016-09-30457,134USD92
2016-01-01 to 2016-09-30983,291USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-09-3010,554,753shares
At 2016-12-3110,722,675shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2017-09-3013,808,596USD
At 2016-12-3112,055,188USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2017-09-30-22,631USD
At 2017-06-30-26,329USD
At 2016-12-31-36,849USD
At 2016-09-30-5,394USD
At 2016-06-30-14,436USD
At 2015-12-31-55,285USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2017-09-303,308,304USD
At 2016-12-312,655,133USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2017-09-301,454,798USD
At 2016-12-311,198,984USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2017-09-30179,785USD
At 2016-12-31173,820USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2017-09-30287,061USD
At 2016-12-31362,900USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2017-07-01 to 2017-09-30224,777USD92
2017-01-01 to 2017-09-30364,633USD273
2016-07-01 to 2016-09-302,589,513USD92
2016-01-01 to 2016-09-309,437,924USD274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2017-07-01 to 2017-09-30196,091USD92
2017-01-01 to 2017-09-30330,344USD273
2016-07-01 to 2016-09-301,569,526USD92
2016-01-01 to 2016-09-306,123,636USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2017-07-01 to 2017-09-302,551,290USD92
2017-01-01 to 2017-09-306,848,472USD273
2016-07-01 to 2016-09-301,869,927USD92
2016-01-01 to 2016-09-307,217,854USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2017-07-01 to 2017-09-3097,991USD92
2017-01-01 to 2017-09-30255,814USD273
2016-07-01 to 2016-09-3058,903USD92
2016-01-01 to 2016-09-30168,900USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2017-01-01 to 2017-09-30970,705USD273
2016-01-01 to 2016-09-30709,871USD274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2017-07-01 to 2017-09-3020,600USD92
2017-01-01 to 2017-09-3061,799USD273
2016-07-01 to 2016-09-302,634USD92
2016-01-01 to 2016-09-3015,382USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-07-01 to 2017-09-3028,715USD92
2017-01-01 to 2017-09-3079,377USD273
2016-07-01 to 2016-09-30-4,017USD92
2016-01-01 to 2016-09-3023,092USD274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2017-01-01 to 2017-09-301,171,964USD273
2016-01-01 to 2016-09-303,392,722USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-09-30-71,380USD273
2016-01-01 to 2016-09-30648,730USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-09-30273,121USD273
2016-01-01 to 2016-09-301,170,928USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-09-30-334,051USD273
2016-01-01 to 2016-09-30-13,542USD274

Inspect the source

Entity
IRADIMED CORPORATION / CIK 0001325618
Captured
2026-09-20T07:52:33.517Z
SEC response SHA-256
1217db54631fdc625eb836a9c89fbf1ed157044af9ce59b6e200421c6d8ca994

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001325618.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))